Szívelégtelenség: vizsgálatok itt: Malajzia
13 trials · From ClinicalTrials.gov, checked 2026. november 11.. Ask the study team whether a trial fits you.
- 2/3. fázisTaking peopleEfficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Left Ventricular Systolic Dysfunction (MK-1242-036)
- Where
- Kota Bharu, Kota Kinabalu, Kuala Lumpur, Lembah Pantai
- Életkor
- 29 nap to 17 év
- People
- 342 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT05714085 · EU 2022-501238-52-00 - No phaseTaking peopleProduct Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
- Where
- Kuala Lumpur
- People
- 20 000 worldwide
- Run by
- Medtronic
See details and how to joinNCT00271180 - No phaseTaking peopleELEVATE-HFpEF Clinical Study
- Where
- Kota Samarahan, Kuala Lumpur
- Életkor
- 40 év and over
- People
- 700 worldwide
- Run by
- Medtronic Cardiac Rhythm and Heart Failure
See details and how to joinNCT06678841 - No phaseNot yet taking people in MalajziaReal-world Effectiveness and Safety of Savagen (Sacubitril/Valsartan) in Malaysian HFrEF Patients
- Where
- Kajang, Shah Alam
- Életkor
- 18 év to 70 év
- People
- 80
- Run by
- Sunway University
See details and how to joinNCT07907640 - 3. fázisTaking peoplePhase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
- Where
- Alor Star, Johor Bahru, Kota Samarahan, Kuala Terengganu, Kuantan, Kuching, Malacca, Rawang, Sarawak Miri, Seri Manjung, Sungai Buloh
- Életkor
- 40 év and over
- People
- 11 300 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06677060 · EU 2024-514506-32-00 - 3. fázisTaking peopleStudy to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function
- Where
- Kajang, Kota Kinabalu, Kota Samarahan, Kuala Lumpur, Kuala Terengganu, Kuantan, Sungai Buloh
- Életkor
- 18 év to 130 év
- People
- 3850 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06307652 · EU 2023-508162-15-00 - 3. fázisTaking peopleA Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF
- Where
- Alor Star, Cheras, Kajang, Kuala Lumpur, Kuala Terengganu, Kuantan, Kuching, Miri, Sungai Buloh
- Életkor
- 18 év and over
- People
- 6950 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07761117 · EU 2026-526304-79-00 - No phaseTaking peopleLeft Bundle Branch Area Pacing (LBBAP) PMCF Study
- Where
- Kuala Lumpur
- Életkor
- 18 év and over
- People
- 200 worldwide
- Run by
- Abbott Medical Devices
See details and how to joinNCT07217392 - 3. fázisTaking peopleA Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
- Where
- Alor Star, George Town, Johor Bahru, Kajang, Kuala, Kuala Lumpur, Kuantan
- Életkor
- 18 év and over
- People
- 5200 worldwide
- Run by
- Colorado Prevention Center
See details and how to joinNCT06008197 - No phaseTaking peopleiCaReMe Global Registry: Multinational Real-world Evidence in Cardiorenal and Metabolic Diseases
- Where
- Kuala Lumpur
- Életkor
- 18 év and over
- People
- 35 000 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT03549754 - 3. fázisTaking peopleA Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
- Where
- Alor Star, Cheras, Johor Bahru, Kajang, Kangar, Perlis, Kota Bharu, Kuala Lumpur, Kuantan, Kuching, Lembah Pantai, Miri, Muar town, Sungai Buloh, Taiping
- Életkor
- 18 év and over
- People
- 5610 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT07567001 · EU 2025-523717-29-00 - 3. fázisTaking peopleStudy to Evaluate Safety, Tolerability and Efficacy of Inclisiran in Children With Homozygous Familial Hypercholesterolemia
- Where
- Kota Bharu
- Életkor
- 2 év to 11 év
- People
- 9 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT06597006 - 3. fázisTaking peopleStudy to Evaluate Efficacy and Safety of Inclisiran in Children With Heterozygous Familial Hypercholesterolemia
- Where
- Kuala Lumpur
- Életkor
- 6 év to 11 év
- People
- 60 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT06597019